Measuring the Wrong Things?
...cholesterol drug challenged that assumption
Vytorin, a combination of two cholesterol-lowering agents, certainly lowers cholesterol. But patients taking it didn't have any less plaque in a major artery than those taking a less-potent drug
I'm assuming that less plaque generally does translate to fewer adverse events, but the article doesn't...
